coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Guildford East PCN, Guildford · Health Inequalities Profile

    PCN U33566 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    58,760

    Registered population

    59.0% aged 18–64

    21.6%

    Aged 65+

    ICB 18.8% · England 17.9%

    11.1%

    Ethnic minority (non-White)

    5.2% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    8,287

    Hypertension register

    +7.32% in 3 yrs · England +5.60%

    446

    SMI register

    41.7% of Guildford's

    543

    COPD register

    Reviews -1.39% in 3 yrs

    Forecast to 2030

    10,070

    Hypertension patients, 2030

    +1,783 on today

    67.0%

    QRISK ≥20% on statins, 2030

    +4.44pp over 3 yrs

    6.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.0%
    High-risk lipid therapy sits below England.

    Lipid-lowering therapy covers 57.0% of QRISK ≥ 20% patients (England 63.6%) and 62.3% in CKD (England 70.3%), which may reflect escalation gaps.

    12
    Twelve three-year trends trail England's pace.

    Across 25 measures from 2023 to 2025, 12 trail England, including COPD reviews (-1.4% vs England +2.8%) and heart failure reviews (-0.7% vs +8.7%).

    74.3%
    Blood pressure control and screening exceed England.

    Hypertension treatment to target reaches 74.3% (England 70.3%), alongside 76.0% uptake for both cervical (England 66.8%) and breast screening (England 69.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients aged 65+ reach 21.6%, exceeding Guildford, ICB and England benchmarks

    Across six member practices totalling 58,760 registered patients, 21.6% (12,681) are aged 65+, higher than Guildford (17.5%), NHS Surrey Heartlands ICB (18.8%) and England (17.9%). Working-age adults (18-64) represent 59.0% and children (0-17) 19.4%. Based on Census usual residents (not registered patients), 88.9% identify as White, above Guildford (86.9%), the ICB (85.3%) and England (81.1%), with an 11.1% ethnic minority population including 5.2% Asian or Asian British. Projected list growth to 2030 is 4.4% (unverified methodology). An older demographic could increase frailty and chronic disease demand across practices.

    Age profile

    0–1719.4%
    18–6459.0%
    65+21.6%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White88.9%
    Asian5.2%
    Mixed3.1%
    Other1.8%
    Black1.1%

    Older people · falls rows are Guildford local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Guildford LA)2,1632,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)88.9%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)63.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Guildford LA)1,0549819552024/25
    Falls deaths, all ages, per 100,000 (Guildford LA)9.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.6 with 0.0% Core20 share across all six practices

    Guildford East PCN has an average IMD decile of 8.6, above Guildford (7.9), NHS Surrey Heartlands ICB (7.9) and England (5.5). No registered patients reside in national IMD deciles 1 or 2 (0.0% Core20), against 1.0% in Guildford, 0.8% in NHS Surrey Heartlands ICB and 21.0% in England. Practice deciles range from 6.5 at Villages Medical Ctr to 9.1 at Merrow Park Surgery, with 0.0% Core20 across all six practices. Area-based deprivation indices may overlook household-level need, suggesting the PCN focus on clinical vulnerability and inclusion health.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Austen Road0.0% · 0 patients
    Merrow Park0.0% · 0 patients
    Villages Medical0.0% · 0 patients
    Sheresurgeryanddispensary0.0% · 0 patients
    Horsley Medical0.0% · 0 patients
    St. Luke's0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    446

    SMI register

    0.75% recorded prevalence

    178

    Learning disability register

    0.30% recorded prevalence

    25

    Care homes, 858 beds

    In the PCN catchment

    8.0%

    Provide unpaid care

    Guildford, Census 2021

    Learning disability prevalence is 0.3% (178 patients; Guildford 0.4%, ICB 0.5%, England 0.6%) and severe mental illness is 0.8% (446 patients; England 1.0%), alongside 25 catchment care homes (858 beds). Borough unpaid care (8.0%) and rough sleeping (9) are borough metrics not captured at PCN level. Lower recorded learning disability prevalence may reflect identification differences, which a clinical register audit would test.

    Severe mental illness: physical health checks

    Recorded SMI checks reach 88.4% for blood pressure (England 83.4%) and 88.4% for BMI (England 82.1%). Over 2023 to 2025, smoking cessation support fell 3.1 pp (England +0.1 pp) to 93.2%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,287

    Hypertension register

    +7.32%

    Register growth, 3 yrs

    Guildford +5.63% · England +5.60%

    +1.15pp

    BP control, under 80

    ≤140/90 · +3.31pp aged 80+

    +1,783

    More patients by 2030

    Forecast 10,070 (16.07%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.9% (8,287 patients), below England (15.2%) and NHS Surrey Heartlands ICB (14.3%) but above Guildford (12.5%). Across practices, recorded prevalence varies from 11.5% at Austen Road Surgery to 16.4% at Villages Medical Ctr. Blood pressure control is strong: 74.3% of patients are treated to target, exceeding England (70.3%), Guildford (72.2%) and the ICB (71.4%). Prevalence differences do not establish undiagnosed disease, but variation alongside high blood pressure control could reflect case-finding differences that an audit would test.

    Lipids and statins

    Lipid-lowering therapy rates trail England across high-risk cohorts: 57.0% for QRISK ≥ 20% (England 63.6%), 62.3% for CKD (England 70.3%), and 81.2% for diabetes with CVD history (England 84.4%). Lower treatment rates across these high-risk cohorts suggest prioritising a systematic clinical recall review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202662,216£2.20£2.24£1.86£136,875
    Cardiovascular (all), 202585,891£6.16£4.74£3.33£529,089

    For lipid-regulating drugs in 2026, the PCN prescribed 62,216 items at £2.20 per item (England £1.86, Guildford £2.15, NHS Surrey Heartlands ICB £2.24), spending £21,153 more than at England's unit cost. Unit cost reflects prescribing choices and formulary mix rather than efficiency, which a local prescribing review would examine.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.38%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.37%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 5.9% (3,360 patients; England 6.6%), and COPD prevalence is 0.9% (543 patients; England 1.9%). While annual reviews exceed national rates—reaching 70.4% in asthma (England 65.7%) and 80.7% in COPD (England 76.4%)—three-year trajectories lag, with COPD reviews falling 1.4% (England +2.8%). An estimated 995 asthma patients remain unreviewed, and youth asthma prescribing is 609 items per 1,000 aged 5–19 (England 1,488). Structured respiratory recalls could address unreviewed cohorts.

    Cancer register and children's immunisation

    Cancer prevalence reaches 5.0% (2,956 patients; England 3.8%). Childhood immunisations show 6-in-1 coverage at 12 months reaching 96.6% and MMR1 at age 5 reaching 95.0%. However, age-5 completion falls below the 95% target by 5 pp for MMR2 (90.0%) and by 11.7 pp for the 4-in-1 booster (83.3%). Structured call-and-recall could support second-dose coverage before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.6%

    England 91.0%

    6-in-1 complete primary course at 24 months95.9%

    England 92.2%

    MMR dose 1 at 24 months93.9%

    England 88.3%

    MMR dose 2 at age 590.0%

    England 82.8%

    4-in-1 pre-school booster at age 583.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    Across NHS Surrey Heartlands ICB in 2022, 61.4% of cancers with a known stage were diagnosed at stage 1 or 2 (2,955 of 4,810 staged cases; England 55.3%), below the 75.0% national ambition by 2028, representing about 650 extra early-stage cases a year across the system. Cancers with a known stage accounted for 67.7% of registered cancers (4,810 of 7,106; England 67.0%). Early-stage share was 48.1% for bowel cancer (England 47.0%) and 33.2% for lung cancer (England 33.8%). These system figures describe regional staging rather than PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For cancer waiting times in provisional July 2026, Royal Surrey NHS Foundation Trust achieved 84.5% on the 62-day referral to treatment standard (standard 85.0%), ahead of Frimley Health NHS Foundation Trust (81.8%), Ashford and St Peter's Hospitals NHS Foundation Trust (76.4%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). On the 28-day faster diagnosis standard, Royal Surrey reached 82.6% (England 79.3%; standard 75.0%). In July 2026 diagnostics at Royal Surrey, 0.0% waited 6+ weeks for Magnetic Resonance Imaging and 38.5% waited 6+ weeks for Urodynamics - Pressures & Flows.

    Pathways within standard (%)Royal SurreyAshford and St Peter'sFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)82.6285.5387.9579.2979.32
    31-day treatment (96%)96.4394.2192.8990.4592.50
    62-day referral to treatment (85%)84.4876.3881.8471.5171.16
    Diagnostic waits over 6 weeks (%)Royal SurreyAshford and St Peter'sFrimley HealthEngland
    MRI0.000.0912.8521.40
    CT0.159.270.639.92
    Echocardiography1.550.973.3528.48
    Colonoscopy0.0049.6122.8430.83
    Gastroscopy0.0056.747.4329.02
    All 15 DM01 tests8.8223.127.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In provisional June 2026 community services data, adults aged 65 and older accounted for 69.6% of contacts among Guildford borough residents (76,215 of 109,530 contacts). These borough-level contacts describe local community service activity rather than PCN-level delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access varies by 43.9 percentage points across member practices

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Horsley Medical1050.089.1%83.2%96.2%
    Villages Medical1040.080.0%85.2%96.0%
    Sheresurgeryanddispensary950.079.7%68.4%95.0%
    Austen Road1060.086.4%72.4%94.7%
    St. Luke's Surgery1240.074.3%73.6%85.9%
    Merrow Park1170.045.1%80.4%68.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNGuildfordAssetPCNGuildford
    Care homes (catchment)25 (858 beds)n/aSchools (catchment)81n/a
    Children's centres46Places of worship6078
    Libraries33Homelessness support (VCS)11
    Day centres (VCS)n/a2Carers support groups (VCS)n/a1
    Primary schools (LA maintained)1214Primary academies1019
    Special schools1no data

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    High-risk lipid therapy recall review

    Lipid therapy lags England for QRISK ≥ 20% at 57.0% (England 63.6%, Guildford 57.3%, ICB 59.4%), CKD at 62.3% (England 70.3%), and diabetes with CVD at 81.2% (England 84.4%). For discussion: practices could run pharmacist-led recall and medicines reviews for QRISK ≥ 20% and CKD cohorts not on lipid-lowering therapy. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured annual asthma review recall

    Asthma review coverage is 70.4% of 3,360 patients (England 65.7%, Guildford 67.8%; 3-year change +2.4% vs England +4.4%), leaving 995 (about 1,000) unreviewed. For discussion: the PCN could introduce a shared recall template, flexible clinic slots, and inhaler checks for unreviewed asthma patients. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register validation audit

    Recorded learning disability prevalence is 0.3% (178 patients) against Guildford (0.4%), the ICB (0.5%) and England (0.6%), a benchmark gap range of +33 to +167 patients. For discussion: practices could audit diagnostic coding and cross-check registers with social-care and special-education lists where governance allows. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frailty and anticipatory care review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Target inclusion health cohorts (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation intervention review (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    System pathway review (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Primary care telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · High-risk lipid therapy recall review (p12)Hypertension register · Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Learning disability register validation audit (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15